Live Chat

Should Patients on Xarelto Undergo More Frequent Blood Monitoring?

When Xarelto was first introduced to the general pharmaceutical company, it was touted as a much more convenient alternative to traditional blood thinners like warfarin. The drug was originally prescribed to patients who had undergone knee and hip replacement surgery and who were at a higher risk of blood clots following those procedures. The advantage, Bayer Healthcare claimed, was that patients would not have to be subjected to weekly and inconvenient blood testing while using Xarelto. They aggressively marketed the drug as a “one size fits all” solution to traditional means of blood testing.

Unfortunately, however, many patients have suffered unfortunate side effects after taking the drug. Because doctors supposedly do not have to regularly monitor their patients on Xarelto, they are not as in tune to how their patients are doing. Many patients on the drug have experienced serious bleeding side effects that include internal and excessive bleeding. Unlike warfarin, Xarelto has no antidote to speak of and patients who experience issues may be at risk of hemorrhaging or death if they do not receive immediately medical care. Although not a perfect substitution, warfarin usage requires that patients undergo regular testing, which could more easily alert doctors to any potential problems before they occur. This undoubtedly brings up the issue of whether doctors who prescribe Xarelto should monitor their patients more frequently in order to prevent any possible complications from arising.

Legal Commentary
Xarelto attorneys within our firm are studying, examining and investigating current Xarelto claims on behalf of people or families injured by the drug. Some of the side effects include hemorrhaging, internal bleeding, stroke and or death. If you or a loved one has experienced any side effects while taking Xarelto, contact our Xarelto lawyers to discuss the facts of your potential case. We are available by phone for a free consultation at 1.866.705.7584 or by email at

Drug Litigation